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Abstract
Myosin light chain (MLC) phosphorylation plays important roles in various cellular functions such as cellular morphogenesis,
motility, and smooth muscle contraction. MLC phosphorylation is determined by the balance between activities of Rho-
associated kinase (Rho-kinase) and myosin phosphatase. An impaired balance between Rho-kinase and myosin phosphatase
activities induces the abnormal sustained phosphorylation of MLC, which contributes to the pathogenesis of certain
vascular diseases, such as vasospasm and hypertension. However, the dynamic principle of the system underlying the
regulation of MLC phosphorylation remains to be clarified. Here, to elucidate this dynamic principle whereby Rho-kinase
regulates MLC phosphorylation, we developed a mathematical model based on the behavior of thrombin-dependent MLC
phosphorylation, which is regulated by the Rho-kinase signaling network. Through analyzing our mathematical model, we
predict that MLC phosphorylation and myosin phosphatase activity exhibit bistability, and that a novel signaling pathway
leading to the auto-activation of myosin phosphatase is required for the regulatory system of MLC phosphorylation. In
addition, on the basis of experimental data, we propose that the auto-activation pathway of myosin phosphatase occurs
in vivo. These results indicate that bistability of myosin phosphatase activity is responsible for the bistability of MLC
phosphorylation, and the sustained phosphorylation of MLC is attributed to this feature of bistability.
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Introduction
Signaling networks regulate cellular functions through an
interconnected set of proteins that transmit signaling information
via the network. An impaired balance of signaling molecule
activities induces several diseases. Accordingly, understanding the
principle of system regulation of the balance of signaling
molecules’ activities in cells is essential to establish new strategies
for the prevention and treatment of diseases. However, it is
difficult to monitor the balance of highly interconnected signaling
molecule activities in vivo, and to elucidate the principles by which
a system regulates the balance between activities of signaling
molecules. Mathematical analysis has proven to be an efficient tool
for the elucidation of these regulatory system mechanisms.
Small Rho GTPase and Rho-associated kinase (Rho-kinase)
play an important role in the regulation of MLC phosphorylation
[1]. Rho cycles between two conformational states, the GDP-
bound (inactive) state and the GTP-bound (active) state [2]. Rho
exerts its biological functions through interaction with specific
effectors [3]. Rho-kinase is identified as an effector of Rho, and
Rho activates Rho-kinase downstream of various extracellular
signals [4–6]. There are two Rho-kinase members, Rho-kinase a/
ROCK2/ROKa and Rho-kinase b/ROCK1/ROKb: we will
refer to them collectively as Rho-kinase [1]. Activated Rho-kinase
directly phosphorylates MLC [7]. The phosphorylation of MLC is
also regulated by myosin phosphatase, which consists of three
subunits, a myosin phosphatase targeting subunit (MYPT1), a 20-
kDa small subunit (M20), and a catalytic subunit of the type 1
protein serine/threonine phosphatase family, PP1d[8–10].
MYPT1 is phosphorylated by Rho-kinase and thereby inactivates
myosin phosphatase activity [11]. Therefore, Rho-kinase promotes
actomyosin contraction in two ways: one by direct phosphoryla-
tion of MLC and the other by inactivation of myosin phosphatase
through the phosphorylation of MYPT1 [1]. However, the system
dynamics whereby Rho/Rho-kinase regulates MLC phosphoryla-
tion remains to be clarified.
Abnormal smooth muscle contraction causes diseases such as
hypertension, vasospasm, and asthma [12]. The contractile state
of smooth muscle is driven by phosphorylation of MLC. The
sustained phosphorylation of MLC and MYPT1 are implicated
in the pathogenesis of certain vascular diseases, including
subarachnoid hemorrhage-induced cerebral vasospasm, coronary
vasospasm, essential hypertension, and pulmonary hypertension
[13,14]. Rho-kinase dependent MLC phosphorylation is also
involved in the regulation of endothelial permeability. When
endothelial cells are stimulated with thrombin, MLC phosphor-
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Thrombin dependent sustained MLC phosphorylation is similar
to prolonged phosphorylation of MLC at the lesion site in several
vascular diseases. Understanding the system regulating the
mechanism of MLC phosphorylation is fundamental to the
prevention and treatment of diseases caused by abnormal smooth
muscle contraction.
Dynamic analysis requires quantitative experimental data, for
example, time dependent changes in activities and concentrations
of signaling molecules in vivo. However, such quantitative
experimental data have not been sufficient for the analysis of
dynamics. In endothelial cells, Maeda and colleagues quantita-
tively measured thrombin-induced Rho activation and the
phosphorylation of MLC and MYPT1 in human umbilical vein
endothelial cells (HUVEC) [18]. A high concentration of thrombin
(0.25 U/ml) induces sustained phosphorylation of MLC and
MYPT1, whereas a low concentration of thrombin (0.05 U/ml)
induces transient phosphorylation of MLC and MYPT1. On the
other hand, both high and low thrombin stimuli induce transient
Rho activation, which peaks at 1–2 minutes after thrombin
stimuli, and maximal activity is about 10- and 4-fold over basal
Rho activity, respectively. In each case, Rho activity quickly
returns to basal levels after maximal activation [18]. In addition,
Rho-kinase inhibitor (Y-27632) suppresses the sustained phos-
phorylation of MLC and MYPT1 induced by stimulation with
a high concentration of thrombin [18]. To clarify the mechanism
by which agonist induces the sustained phosphorylation of MLC,
Maeda and colleagues performed computational simulation,
incorporating signaling pathways already known to regulate
MLC phosphorylation. However, this computational simulation
did not reproduce thrombin-dependent sustained MLC phos-
phorylation [18]. These results suggest that an additional path-
way(s) may be required for sustained MLC phosphorylation [18].
We reconsidered the signaling pathway regulating MLC
phosphorylation through Rho/Rho-kinase. In common with
MLC, other substrates of Rho-kinase (ERM family proteins,
adducin, Tau, and MAP2) are regulated by Rho-kinase and
myosin phosphatase [11,19–21]. Since MYPT1 is also a substrate
of Rho-kinase, it is possible that myosin phosphatase undergoes
auto-dephosphorylation following phosphorylation by Rho-kinase.
In fact, the phosphatase inhibitor Calyculin A, which suppresses
the activity of protein phosphatase 1 (PP1) and 2A (PP2A),
accelerates the phosphorylation of MYPT1 [22–24]. Kimura and
colleagues have reported the direct dephosphorylation of MYPT1
by myosin phosphatase in vitro in the following experiment: in an in
vitro phosphatase assay using purified myosin phosphatase, Rho-
kinase, and MLC, they found that the purified myosin phospha-
tase holoenzyme directly dephosphorylates its regulatory subunit,
MYPT1, which has been phosphorylated by Rho-kinase [25]. We
speculate that myosin phosphatase auto-dephosphorylation may
be the so-called additional pathway responsible for sustained MLC
phosphorylation.
In the present study, to examine the characteristics of the system
regulating MLC phosphorylation through Rho/Rho-kinase, we
developed a mathematical model including a hypothetical pathway
by which myosin phosphatase regulates MYPT1 phosphorylation
by Rho-kinase. Our model reproduced the sustained phosphoryla-
tion of MLC and MYPT1 induced by transient Rho-kinase
activation. Thus, myosin phosphatase auto-dephosphorylation, as
anadditionalpathway,isconsideredtobeanecessarycomponentof
the system regulating MLC phosphorylation by Rho/Rho-kinase.
We also demonstrated experimentally that myosin phosphatase
undergoes auto-dephosphorylation in vivo. Moreover, we showed
that the activity of myosin phosphatase and MLC phosphorylation
indicate bistability in our model. The bistable system can adopt
eitheroftwoalternativesteadystatesinresponsetosmallchangesin
stimulus [26]. Hence, we propose that bistability plays a critical role
in the system, whereby Rho/Rho-kinase regulates MLC phosphor-
ylation.
Materials and Methods
Mathematical Modeling, Parameters, and Simulation
All calculations were performed using Mathematica 7 (Wol-
fram). All reactions are represented by enzymatic reactions [27].
The biochemical and enzymatic reactions used in the study are
shown in Figure 1A. All parameters used in our model are listed
with their values in Table I.
Myosin Phosphatase Activity
In our model, the activation of myosin phosphatase is described
by the following combined equation composed of enzymatic
reactions and a first order reaction:
d½MP 
dt
~
kcat1½MP (½MP total{½MP )
Km1z(½MP total{½MP )
{
kcat2½ROCK ½MP 
Km2z½MP 
z
k1(½MP total-½MP )
ð1Þ
where [] denotes the concentration of the molecules at time t.
ROCK denotes the activated form of Rho-kinase. MP denotes
activated myosin phosphatase, which contains non-phosphorylated
MYPT1. The total concentration of myosin phosphatase ([MP]total)
is conserved throughout the reaction. ([MP]total-[MP]) is the
concentrationoftheinactiveformofmyosinphosphatasecontaining
phosphorylated MYPT1. kcat1 and kcat2 are the turnover numbers
ofmyosinphosphataseandRho-kinase,respectively.Km1andKm2
are Michaelis constants. k1 is the rate constant for the reaction.
k1([MP]total-[MP])assumes theactivation ofmyosinphosphatase by
other signaling pathways.
At steady state, the concentration of activated myosin
phosphatase becomes constant. Therefore, by setting equation
(1) equal to zero, we obtained equation (2).
½ROCK ~f
kcat1½MP (½MP total{½MP )
Km1z(½MP total{½MP )
zk1(½MP total{½MP )g
(Km2z½MP )
kcat2½MP 
ð2Þ
Phosphorylation of MLC
Phosphorylation of MLC is also described by the equation
consisting of the enzymatic reactions and the first order reaction:
d½pMLC 
dt
~
kcat3½ROCK (½MLC total{½pMLC )
Km3z(½MLC total{½pMLC )
{
kcat4½MP ½pMLC 
Km4z½pMLC 
zk2(½MLC total{½pMLC )
ð3Þ
where [] denotes the concentration of the molecules at time t.
pMLC denotes phosphorylated MLC. The total concentration of
MLC ([MLC]total) is conserved throughout the reaction. ([MLC]to-
tal-[pMLC]) denotes the concentration of non-phosphorylated
MLC. kcat3 and kcat4 are the turnover numbers of Rho-kinase
and myosin phosphatase, respectively. Km3 and Km4 are
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PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39269Figure 1. Mathematical modeling and simulation of MLC phosphorylation regulated by Rho-kinase. (A) Schematic overview of MLC
phosphorylation regulated by Rho-kinase signal. Arrows, dashed line and - indicate stimulatory enzymatic reactions, myosin phosphatase auto-
dephosphorylation signaling pathway and phosphorylation, respectively. (B) The graph shows that the transient Rho-kinase activations (red and blue
line) are given as the input signal in our simulation. (C)(D) The simulation results of MLC and MYPT1 phosphorylation induced by the transient Rho-
kinase activation in Figure 1B. (E)(F) The phosphorylation of MYPT1 and MLC against time t was calculated using the various kcat2 values. (G) The
phosphorylation of MLC against time t was calculated using the different kcat3 values.
doi:10.1371/journal.pone.0039269.g001
Table 1. Parameter values for mathematical model.
Parameter Value Comments
Km1 16 mM Assumption
kcat1 3/sec Assumption
Km2 0.1 mM Feng et al. J Biol Chem. 274, 3744–3752, 1999
kcat2 2.357/sec Feng et al. J Biol Chem. 274, 3744–3752, 1999
Km3 2.47 mM Feng et al. J Biol Chem. 274, 3744–3752, 1999
kcat3 1.8/sec Feng et al. J Biol Chem. 274, 3744–3752, 1999
Km4 16 mM Ichikawa et al. J Biol Chem. 271, 4733–4740, 1996
kcat4 13.5/sec Ichikawa et al. J Biol Chem. 271, 4733–4740, 1996
[RhoK]total 0.047 mM Suzuki et al. Blood, 93(10), 3408–3417, 1999
[MLC]total 5 mM Kuroda et al. In Foundations of System Biology 279–294, 2001
[MP]total 1.2 mM Kuroda et al. In Foundations of System Biology 279–294, 2001, Maeda et al. Genes Cells 11, 1071–1083, 2006
k1 0.01 mM Fit to experimental data
k2 0.01 mM Fit to experimental data
doi:10.1371/journal.pone.0039269.t001
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denotes the rate constant for the reaction. k2([MLC]total-[pMLC])
assumes the phosphorylation of MLC by other signaling pathways.
Materials and Chemicals
Inhibitor and antibodies were obtained from commercial
sources. Calyculin A was obtained from Wako Co. (Osaka, Japan).
cDNA-encoding human CPI-17 was purchased from Invitrogen
Co. (Carlsbad, CA, USA). pCAGGS-myc-kk1 vector was provided
by Dr. K. Kaibuchi (Nagoya University, Nagoya, Japan).
Plasmid Constructs
cDNA fragment encoding CPI-17 full length was amplified by
polymerase chain reaction (PCR) using the obtained cloned as
a template, containing the entire open reading frame of human
CPI-17. The CPI-17 mutants, T38D and T38A, were generated
with a site-directed mutagenesis kit (Stratagene, La Jolla, CA,
USA) by replacing Thr-38 with Asp-38 or Ala-38. The cDNA
fragments were subcloned into pCAGGS-myc-kk1 vector.
Culture Preparation
HEK293 cells were grown in Dulbecco’s modified eagle
medium (DMEM) containing 10% fetal bovine serum (FBS) at
37uC in an air-5% CO2 atmosphere at constant humidity.
Transfection of plasmid into cells was carried out using Hillymax
reagent (Dojindo, Kumamoto, Japan) according to the manufac-
turer’s protocol. For the treatment of Calyculin A, cells were
seeded onto 6 well plates coated with poly-D-lysine (PDL) and
cultured overnight.
MYPT1 Phosphorylation
After treatment with 0.1 mM Calyculin A for 10 min and
transfection, cells were harvested with 10% (w/v) trichloroacetic
acid. The resulting precipitates were subjected to immunoblotting
with anti-phospho-MYPT1 (Thr-853) antibody (Millipore, Bill-
erica, MA, USA), anti-MYPT1 antibody (BD, Lakes, NJ, USA),
and anti-myc antibody (Millipore, Billerica, MA, USA).
Results
Modeling the System Responsible for Regulation of MLC
Phosphorylation by Rho/Rho-kinase Signaling
To examine the dynamics whereby Rho/Rho-kinase regulates
MLC phosphorylation, we constructed the mathematical model
based on previous experimental results showing thrombin-de-
pendent MLC phosphorylation in endothelial cells [18]. Our
simple mathematical model incorporates only three components,
Rho-kinase, myosin phosphatase, and MLC (Figure 1A). Rho-
kinase phosphorylates MYPT1, a regulatory subunit of myosin
phosphatase. The activity of myosin phosphatase is suppressed
through MYPT1 phosphorylation by Rho-kinase. Myosin phos-
phatase incorporating non-phosphorylated MYPT1 can be
regarded as an active form of myosin phosphatase. In our model,
the concentration of non-phosphorylated MYPT1 is considered to
represent that of activated myosin phosphatase. Some substrates of
Rho-kinase are regulated by myosin phosphatase, and MYPT1 is
a substrate of Rho-kinase. Thus, we assumed that myosin
phosphatase dephosphorylates MYPT1, as a hypothetical pathway
(myosin phosphatase auto-dephosphorylation pathway) (Dashed
line in Figure 1A). Mathematical details of the model are
provided in the Materials and Methods and Table I, along with
a list of parameters and the basis on which they were chosen. We
determined the kinetic parameters based on experimental
observations and some assumptions (Table I).
A Myosin Phosphatase Auto-dephosphorylation Pathway
is Required for the Sustained Phosphorylation of MLC
To test the validity of our mathematical model, the simulation
results were compared with the already-known experimental data
(phosphorylation profiles of MLC and MYPT1). It has been
reported that stimulation with a high concentration of thrombin
gives rise to sustained phosphorylation of MLC and MYPT1 in
vivo, whereas stimulation with a low concentration leads only to
transient phosphorylation of MLC and MYPT1 [18]. In contrast,
stimulation with 0.25 U/ml (high) or 0.05 U/ml (low) thrombin
yields high or low peaks of transient Rho activation in vivo [18].
Therefore, for simplification of our model, the high and low peak
transient activities of Rho-kinase were applied to our simulation as
the input signals. For each signal, 0.030 mM activated Rho-kinase
was used in our simulation as the set of initial conditions
(Figure 1B). With the high peak activation signal, the concen-
tration of activated Rho-kinase was transiently raised from
0.030 mM to 0.047 mM for only 100 seconds (100–200 sec)
(Red line in Figure 1B). On the other hand, with the low
peak activation signal, the concentration of activated Rho-kinase
was increased from 0.030 mM to 0.037 mM over the same 100
second interval (100–200 sec) (Blue line in Figure 1B). Each
signal returned to the basal level of Rho-kinase activity (0.030 mM)
after transient activation.
We analyzed the dynamic behavior of MLC phosphorylation.
We simulated the time course of phosphorylation of MLC
according to equations (1) and (3) in Materials and Methods.
The transient Rho-kinase activations are described in Figure 1B.
When the transient Rho-kinase activations were used, the
phosphorylation of MLC against time t was simulated using
equations (1) and (3) (Figure 1C). We used 0.1 mM phosphor-
ylated MLC as the initial condition. The low peak activation of
Rho-kinase transiently increased phosphorylation of MLC, which
then returned to the basal level of phosphorylation (Blue line in
Figure 1C). In contrast, the high peak activation of Rho-kinase
also increased the phosphorylation of MLC, which was main-
tained (Red line in Figure 1C). Correspondingly, we analyzed
the dynamic behavior of MYPT1 phosphorylation. With high and
low transient activation of Rho-kinase, the phosphorylation of
MYPT1 against time t was simulated using equation (1)
(Figure 1D). We used 0.86 mM activated myosin phosphatase
as an initial condition. The high peak activation of Rho-kinase
induced the sustained phosphorylation of MYPT1, whereas low
peak activation of Rho-kinase transiently increased the phosphor-
ylation of MYPT1 (Blue and Red lines in Figure 1D). These
results are consistent with the experimental dynamics of thrombin-
induced phosphorylation of MLC and MYPT1 [18].
Sustained Phosphorylation of MLC and MYPT1 is
Suppressed by Inhibition of Rho-kinase Activity
It has been reported that the sustained phosphorylation of MLC
and that of MYPT1 are repressed by the Rho-kinase specific
inhibitor Y-27632 in vivo [18]. To examine the effects of Rho-
kinase inhibition, we performed stepwise changes in the turnover
number (kcat2 in Figure 1A) value of Rho-kinase towards MYPT1
in our model. The phosphorylation of MYPT1 against time t was
calculated using the various kcat2 values (kcat2=1.800, 2.000,
2.100, and 2.375) of Rho-kinase, using equation (1) in Materials
and Methods (Figure 1E). Correspondingly, the phosphorylation
of MLC against time t was calculated using the various kcat2
Dynamic Regulation of MLC Phosphorylation
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of MYPT1 by Rho-kinase, using equations (1) and (3) in Materials
and Methods (Figure 1F). In these simulations, the transient high
peak of Rho-kinase activity was used (Red line in Figure 1B).
We showed that the phosphorylation of MYPT1 and MLC was
altered from sustained to transient by the stepwise reduction in
Rho-kinase turnover number (kcat2) towards MYPT1 (Figure 1E
and F). Furthermore, we demonstrated that a slight increase in
turnover number produced sustained phosphorylation of MYPT1
and MLC (Orange and green lines in Figure 1E and F).
These results suggest that there is a threshold, above which there is
a sustained MLC phosphorylation response, in this reaction. We
also assessed the effect of suppression of the turnover number
(kcat3 in Figure 1A) value of Rho-kinase for direct phosphorylation
of MLC in our simulation. Furthermore, the phosphorylation of
MLC against time t was calculated using the various kcat3 values
(kcat3=0 and 1.8) for direct phosphorylation of MLC by Rho-
kinase, and using equations (1) and (3) in Materials and Methods
(Figure 1G). Despite the suppression of direct MLC phosphor-
ylation by Rho-kinase, MLC phosphorylation was maintained,
even though phosphorylation level in the sustained phase was low
(Figure 1G). As compared with the results of the suppression of
kcat2 and kcat3 (Figure 1F and G), the suppression of kcat2 has
an influence on the sustained MLC phosphorylation. On the
regulation of MLC phosphorylation by Rho-kinase, our simulation
results suggest that the major effect of Rho-kinase is suppression of
myosin phosphatase activity rather than direct MLC phosphor-
ylation. These results may agree with the previous observation that
myosin phosphatase plays a pivotal role in controlling phosphor-
ylation of MLC in response to physiological stimuli. We
reproduced the sustained MLC phosphorylation induced by
transient activation of Rho-kinase; this is a signal upstream of
MLC, in our simulation, incorporating the hypothesis that myosin
phosphatase dephosphorylates its regulatory subunit, MYPT1. On
the basis of our simulation results, it is reasonable to assume that
MYPT1 is dephosphorylated by myosin phosphatase in our
mathematical model.
Myosin Phosphatase Regulates Phosphorylation of
MYPT1 In Vivo
We determined experimentally whether MYPT1 is depho-
sphorylated by myosin phosphatase, using a phosphatase inhibitor
and myosin phosphatase inhibitory protein. Calyculin A is an
inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), and
myosin phosphatase is a PP1. We found that Calyculin A induced
an increase in MYPT1 phosphorylation at Thr-853, which is
a phosphorylation site of Rho-kinase (Figure 2A). These results
indicate that MYPT1 is dephosphorylated by PP1 or PP2A, in
agreement with previous reports [22–24]. It is known that
a 17 kDa protein kinase C (PKC)-potentiated phosphatase in-
hibitory protein (CPI-17), phosphorylated at Thr-38, interacts with
a catalytic subunit of myosin phosphatase and suppresses myosin
phosphatase activity [28]. Thus, CPI-17 is considered to act as an
inhibitory protein for myosin phosphatase. We produced CPI-17
mutants (CPI-17 T38D and T38A), in which Thr-38 was replaced
by Asp or Ala. The expression of CPI-17 T38D, which was
expected to mimic the behaviour of phosphorylated CPI-17,
clearly induced an increase of MYPT1 phosphorylation at Thr-
853, whereas CPI-17 WT and T38A only slightly increased the
phosphorylation of MYPT1 (Figure 2B). These results indicate
that myosin phosphatase regulates the phosphorylation level of
MYPT1. Therefore, it is appropriate to assume that myosin
phosphatase directly dephosphorylates MYPT1 in our model.
Bistable Response of Myosin Phosphatase Activity
To investigate the dynamics whereby Rho/Rho-kinase reg-
ulates the phosphorylation of MLC, we analyzed the steady states
of myosin phosphatase activity using the mathematical model.
Since MYPT1 phosphorylated by Rho-kinase decreases its
phosphatase activity, myosin phosphatase consisting of non-
phosphorylated MYPT1 is assumed to represent the active form.
We plotted the concentration of myosin phosphatase active form,
denoted [MP], against its derivative with respect to time, which is
denoted by d[MP]/dt using equation (1) in Materials and
Methods, when activated Rho-kinase is 0.030 mM (Figure 3A).
At the steady states, the concentration of activated myosin
phosphatase, [MP], is constant. In other words, the reaction
velocity is zero, which means that the differentiation of activated
myosin phosphatase concentration against time, d[MP]/dt, is
zero. The plots showed the presence of three intersections with the
horizontal axis (S1, S2, and S3 in Figure 3A), each of which
corresponds to a steady state, because the rate of change at these
points is zero (Figure 3A). d[MP]/dt exhibits the rate of change
of [MP], for example, d[MP]/dt .0 indicates an increase in
concentration of [MP], whereas d[MP]/dt ,0 indicates a decline
in [MP]. The plots indicate that [MP] converges to S1 or S3, when
the system is given a slight perturbation in the vicinity of S1 and
S3. However, the perturbation around S2 induces convergence to
S1 or S3, but not S2. Thus, the system acquired two stable steady
states, S1 and S3, separated by the unstable steady state S2
(Figure 3A). These results suggest that the activity of myosin
phosphatase is bistable in our model under these conditions.
Figure 2. Inhibition of myosin phosphatase induces phosphor-
ylation of MYPT1. (A) HEK293 cells were treated with 0.1 mM
Calyculin A. Cell lysates were resolved by SDS-PAGE and immuno-
blotted with anti-phospho-MYPT1 (Thr-853), and anti-MYPT1 antibo-
dies. (B) The lysates of cells expressing the indicated proteins were
immunoblotted with anti-phospho-MYPT1 (Thr-853), anti-MYPT1, and
anti-myc antibodies.
doi:10.1371/journal.pone.0039269.g002
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steady states, in contrast to a monostable system, which slides
along a continuum of steady states [29–36]. If myosin phosphatase
activity is bistable, its activity converges to one of two stable states
depending on initial state or external perturbations. Considering
the behavior of a bistable system, if the activation of Rho/Rho-
kinase exceeds a threshold due to stimulus by an extracellular
signal, for example thrombin, it may trigger transition from the
upper to the lower stable steady state of myosin phosphatase
activity. Once the transition from the higher to the lower stable
steady state occurs, the low activity of myosin phosphatase is
maintained, even if the activation of Rho/Rho-kinase is decreased.
It is possible that an irreversible transition of myosin phosphatase
activity results in sustained MLC phosphorylation. The Rho-
kinase specific inhibitor Y-27632 suppresses the sustained phos-
phorylation of MLC and MYPT1 in vivo [18]. To characterize the
steady states of myosin phosphatase activity against Rho-kinase
activity, d[MP]/dt was plotted against [MP] using the various
kcat2 values (kcat2=0.500, 1.000, 1.500, 2.000, 2.375, 2.500 and
3.000) of Rho-kinase against MYPT1 (Figure 3B). The number
of intersections with the horizontal axis was altered from three to
one by the stepwise change of kcat2 value (Figure 3B).T o
characterize the steady states of myosin phosphatase activity
against Rho-kinase, d[MP]/dt was plotted against [MP] using the
various Michaelis constant values (Km2=0, 0.02, 0.04, 0.06, 0.08,
0.10, and 1.02) for phosphorylation of MYPT1 by Rho-kinase,
and using equation (1) in Materials and Methods (Figure S1A).
The stepwise change of Km2 value also altered the number of
Figure 3. Activity of myosin phosphatase is bistable. [MP] denotes the concentration of activated myosin phosphatase. The concentration of
activated myosin phosphatase is assumed to represent that of non-phosphorylated MYPT1. d[MP]/dt indicates the differentiation of [MP] against time
t. (A) The plots are d[MP]/dt against [MP]. In the steady states, the reaction velocity is zero, whereby the steady states are d[MP]/dt=0. Three
intersections with the horizontal axis represent three steady states (S1, S2, and S3). (B) d[MP]/dt was plotted against [MP] using the various kcat2
values. (C) d[MP]/dt was plotted against [MP] using the various kcat1 values.
doi:10.1371/journal.pone.0039269.g003
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S1A). These results suggest that Rho-kinase inhibition altered the
system from bistable to monostable, thereby inhibiting sustained
MLC phosphorylation.
We assumed that MYPT1 is dephosphorylated by myosin
phosphatase, representing a myosin phosphatase auto-dephosphor-
ylation signaling pathway. To identify the steady states of myosin
phosphatase activity against the strength of the myosin phosphatase
auto-dephosphorylation signal pathway, d[MP]/dt was plotted
against[MP]usingthevariouskcat1values(kcat1=1.5,2.0,2.5,3.0,
3.5, 4.0, and 4.5) of myosin phosphatase (for dephosphorylation of
MYPT1), and using equation (1) in Materials and Methods
(Figure 3C). Likewise, to examine the steady states of myosin
phosphatase activity against Rho-kinase activity, d[MP]/dt was
plotted against [MP] using the various Km1 values (Km1=10, 12,
14, 16, 18, 20, and 22) for dephosphorylation of MYPT1 by myosin
phosphatase, and also using equation (1) in Materials and Methods
(FigureS1B).Thenumberofintersectionswiththehorizontalaxis
was shifted from three to one by the stepwise change of kcat1 and
Km1 value (Figure 3C and Figure S1B). These results suggest
that the system was changed from bistable to monostable in
proportion to the extent of involvement of the myosin phosphatase
auto-dephosphorylation signaling pathway.
Bistability of Myosin Phosphatase Activity Induces
Sustained MLC Phosphorylation
We first examined the relationship between Rho-kinase activity
and the steady states of myosin phosphatase activity in our
mathematical model. We obtained a bifurcation diagram from
equation (2) in Materials and Methods (Figure 4A). The
bifurcation diagram revealed the steady states of activated myosin
phosphatase ([MP]) against Rho-kinase activities ([ROCK])
(Figure 4A). The hysteretic behavior of the system can be
deduced from the results shown in Figure 4A; the elevation of
Rho-kinase activity from low to high leads to the lower branch in
the bistable curve of stable states of activated myosin phosphatase,
whereas decreasing from high to low takes myosin phosphatase
activity on the upper branch. These results suggest that myosin
phosphatase activity is bistable. To evaluate the range of Rho-
kinase activities leading to the bistability of myosin phosphatase
activity, the steady state of myosin phosphatase activity was plotted
against Rho-kinase activity and the rate constant (k1). This plot
suggests that a wide range of Rho-kinase activities induce myosin
phosphatase activity (Figure S2).
Secondly, to investigate the correlation between the steady
states of MLC phosphorylation and Rho-kinase activity, we
obtained the value of [MP] against [ROCK] from equation (2) in
Materials and Methods. At the steady state, the concentrations of
phosphorylated MLC ([pMLC]) become constant. By setting
equation (3) in Materials and Methods equal to zero and
substituting the value of [ROCK] and [MP] obtained from
equation (2) into equation (3), [pMLC] was calculated. The
bifurcation diagram was obtained by plotting [pMLC] against
[ROCK] (Figure 4B). The bifurcation diagram indicated the
bistability of MLC phosphorylation against Rho-kinase activity.
Therefore, the bistability of myosin phosphatase activity leads to
the bistable phosphorylation of MLC, and the property of
bistability is responsible for the sustained phosphorylation. These
results suggest that the steady state of MLC phosphorylation
converges from low to high in excess of the threshold, due to the
transient Rho-kinase activity. Consequently, transient Rho-kinase
activation induces sustained MLC phosphorylation; the pharma-
cological action of a Rho-kinase inhibitor induces the transition
from high to low steady state of MLC phosphorylation.
Discussion
In this study, to elucidate the system dynamics, we developed
a mathematical model in which Rho/Rho-kinase regulates MLC
phosphorylation. We hypothesized that myosin phosphatase
dephosphorylates MYPT1 phosphorylated by Rho-kinase. We
demonstrated that our mathematical model incorporating the
myosin phosphatase auto-dephosphorylation pathway reproduces
the sustained phosphorylation of MLC and MYPT1 induced by
transient activation of Rho-kinase. These results support our
hypothesis that myosin phosphatase dephosphorylates the regula-
tory subunit of MYPT1. We showed that the activity of myosin
phosphatase and MLC phosphorylation are bistable. Furthermore,
the transition of myosin phosphatase activity from monostable to
bistable depends on Rho-kinase. The bistability of myosin
phosphatase activity is responsible for the bistability of MLC
phosphorylation, and the sustained phosphorylation of MLC is
attributed to the feature of bistability.
Figure 4. Bistability of myosin phosphatase activity induces
sustained phosphorylation of MLC. (A) The bifurcation diagram
shows the steady states of activated myosin phosphatase against Rho-
kinase activity. The longitudinal axis is the steady state of myosin
phosphatase activity. The horizontal axis shows the concentration of
activated Rho-kinase. (B) The bifurcation diagram indicates the steady
states of phosphorylated MLC against Rho-kinase activities. The
longitudinal axis shows the steady state of phosphorylated MLC. The
horizontal axis shows the concentration of activated Rho-kinase.
doi:10.1371/journal.pone.0039269.g004
Dynamic Regulation of MLC Phosphorylation
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39269MLC phosphorylation status is determined by the balance
between activities of kinases including Ca
2+/calmodulin-dependent
MLC kinase (MLCK) and Rho-kinase, and myosin phosphatase
[37,38]. Several agonists induce biphasic MLC phosphorylation,
which consists of initial (phasic) and sustained (tonic) phases. The
initial phosphorylation of MLC is regulated by Ca
2+/Calmodulin-
dependent MLCK signaling, whereas the sustained phosphoryla-
tion of MLC is regulated by Rho/Rho-kinase signaling [18,39–41].
PreviousstudieshaveshownthatMLCKinhibitorML-9,selectively
suppresses transient initialMLCphosphorylation, butnotsustained
MLC phosphorylation [41]. In contrast, Rho-kinase inhibitor
significantly suppresses the sustained phosphorylation of MLC
[18]. These results indicate that MLCK does not contribute to
sustained MLC phosphorylation, and that Rho-kinase is a major
regulator of MLC sustained phosphorylation. Since we focused on
sustained MLC phosphorylation, our mathematical model does not
include MLCK signaling. It is known that CPI-17 inhibits myosin
phosphatase in a PKC-mediated phosphorylation-dependent man-
ner [42]. However, thrombin does not induce significant phosphor-
ylation of CPI-17 in endothelial cells [43]. Our model was based on
the experimental results of thrombin-dependent MLC phosphory-
lation in endothelial cells. Thus, the CPI-17 signaling pathway was
excluded from our mathematical model.
Rho-kinase has been reported to phosphorylate MYPT1 at
Thr-696 and Thr-853 [1]. The phosphorylation of Thr-696 and
Thr-853 in MYPT1 inhibits myosin phosphatase activity and
interaction with myosin [44–47]. In smooth muscle and non-
muscle cells, myosin phosphatase catalyses the reactions of
dephosphorylation of MLC at Ser-19, regulating actomyosin
relaxation [12]. The sequence of the regulatory phosphorylation
site in MYPT1 around Thr-696 and Thr-853 resembles that of
MLC around Ser-19 [48]. Therefore, this sequence is also a good
candidate for binding at the catalytic cleft of myosin phosphatase,
since charge complementarity exists between this sequence and
the catalytic cleft of myosin phosphatase [48]. It is likely that
myosin phosphatase controls phosphorylation of MYPT1 at Thr-
696 or Thr-853. Furthermore, Calyculin A, an inhibitor of PP1
and PP2A, increases the phosphorylation of MYPT1 at Thr-696
and Thr-853 in vivo [22–24]. We confirmed that treatment with
Calyculin A induced the phosphorylation of MYPT1 at Thr-853
(Figure 2A). These results suggest that the phosphorylation of
MYPT1 is regulated by PP1 or PP2A. Since myosin phosphatase
is a PP1, these previous observations support the hypothesis that
myosin phosphatase regulates the phosphorylation of MYPT1.
Moreover, we found that the phosphorylation of MYPT1 was
elevated by overexpression of CPI-17 phospho-mimic mutant
(CPI-17 T38D), which suppresses myosin phosphatase activity
(Figure 2B). In addition to our experimental data, Kimura and
colleagues have reported that the purified holoenzyme of myosin
phosphatase exhibits phosphatase activity toward myosin phos-
phatase phosphorylated by Rho-kinase in vitro [25]. This result
strongly indicates that myosin phosphatase directly dephosphor-
ylates itself. Taken together, it is appropriate to assume that
myosin phosphatase dephosphorylates MYPT1 in our model,
resulting in reproduction of the sustained MLC phosphorylation
induced by transient Rho-kinase activation.
A bistable signaling system must include a positive feedback
loop, a double-negative feedback loop, or the equivalent [26].
However, the presence of positive or negative feedback does not
guarantee that a system will be bistable. The positive and negative
feedback loops exhibit bistability in parameter dependent
manners. In our model, the myosin phosphatase auto-dephos-
phorylation signaling pathway serves as a positive feedback loop,
because Rho-kinase suppresses myosin phosphatase activity
through phosphorylation of MYPT1. We used the parameters
obtained from the previous experimental observations as far as
possible (Table I), whereby the activity of myosin phosphatase
indicates bistability. Since the phosphorylation of MLC is
regulated by myosin phosphatase, the phosphorylation of MLC
also exhibits bistability. ERM family proteins, adducin, Tau and
MAP2 are found to be substrates of both Rho-kinase and myosin
phosphatase [11,19–21]. It is possible that the phosphorylation of
these substrates also exhibits bistability. However, further study is
necessary to address whether phosphorylation of these substrates
may exhibit bistability.
Bistability can adopt either of two alternative steady states in
response to a constant stimulus, and can toggle between alternative
stable steady states in response to small changes in stimulus or
transient stimulus [26]. A bistable system will convert a transient
trigger stimulus into an irreversible response. In Xenopus oocyte
maturation, ERK1/2 achieves a bistable form following a single
stimulation with progesterone [49]. The bistability of MLC
phosphorylation toggles between alternative stable steady states
in response to small changes in stimulus and transient supra-
threshold Rho/Rho-kinase activity. This prediction agrees with
the experimental observation that transient Rho activation
induced sustained phosphorylation of MLC. The bistable system
is resistant to perturbations; it may robustly regulate the
phosphorylation of MLC and the activity of myosin phosphatase.
Rho-kinase specific inhibitor Y-27632 suppresses the sustained
phosphorylation of MLC and MYPT1 in vivo [18]. Rho-kinase
inhibitors appear to be useful for treating disorders of vascular
smooth muscle cells (e.g. hypercontraction, and arteriosclerotic
diseases), and other smooth muscle cell types (e.g. bronchial
asthma and glaucoma) [50]. It is possible that MLC phosphor-
ylation usually converges to a lower stable steady state, but to
a higher steady state at the lesion site. Some perturbation may
cause the transition from a lower to a higher steady state at the
lesion site. When Rho-kinase activity is gradually decreased, MLC
phosphorylation abruptly transits from a higher to a lower steady
state at the threshold (Figure 4B). Therefore, the pharmacolog-
ical action of Rho-kinase specific inhibitors may cause transition
from a higher to a lower steady state.
Understanding the dynamics regulating MLC phosphorylation
is essential to establish new strategies for the prevention and
treatment of diseases of blood vessels and several other areas.
This study sheds light on the dynamics underlying the regulation
of MLC phosphorylation by Rho/Rho-kinase signaling. We
predict that the positive feedback loop is required for the
sustained MLC phosphorylation, and that the sustained MLC
phosphorylation is regulated by bistability of myosin phosphatase
activity. However, further experimental studies are required to
determine whether myosin phosphatase dephosphorylates
MYPT1 phosphorylated by Rho-kinase, and whether the
phosphorylation of MLC and MYPT1 indicates bistability in
vivo. Understanding the dynamics by which Rho/Rho-kinase
regulates MLC phosphorylation in living cells will be a challenge
for further experimental investigations.
Supporting Information
Figure S1 Effects of Rho-kinase and hypothetical path-
way. (A) d[MP]/dt was plotted against [MP] using the various
Km2 values (Km2=0, 0.02, 0.04, 0.06, 0.08, 0.10, and 1.02) for
phosphorylation of MYPT1 by Rho-kinase. (B) d[MP]/dt was
plotted against [MP] using the various Km1 values (Km1=10, 12,
14, 16, 18, 20 and 22) for dephosphorylation of MYPT1 by
myosin phosphatase.
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Figure S2 Estimation of Rho-kinase activity and rate
constant k1. The steady states of activated myosin phosphatase
against Rho-kinase activity and rate constant (k1). X, Y, and Z axes
show the Rho-kinase activities, rate constant k1, and the steady
states of myosin phosphatase, respectively.
(TIF)
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